medigraphic.com
Anales de Otorrinolaringología Mexicana

2023, Number 3

<< Back Next >>

Otorrinolaringología 2023; 68 (3)

Lip hemangioma, how did we solve it

Casas OJ, López VA, Rincón J

Language: Spanish
References: 40
Page: 147-155
PDF size: 251.84 Kb.


ABSTRACT

Background: The most common benign tumor in childhood and adolescence is the hemangioma, it is more frequent in the female sex, in the head and neck area (60%), less frequent in the oral cavity, located on the lips, tongue, buccal mucosa; of red or bluish red color, variable size, changes color to digital pressure, slow growth, and the puncture is diagnostic. Spontaneous resolution occurs in 50%, and 90% of lesions resolve before nine years of age. The most frequent complication is ulcer with or without infection in 20% of cases. Treatments include mechanical compression, corticosteroids, embolization, laser therapy, cryosurgery, and electrocoagulation; the scar is the most frequent complication secondary to treatment.
Clinical case : A 25-year-old female patient with a bluish lesion in the right labial commissure extending to the mucosa of the cheek, non-painful, slow-growing, without limitation to the mouth opening, selective embolization was performed, and then arterial clipping in a second time. Both procedures were unsuccessful, so we proposed treatment with radiofrequency (Coblator).
Conclusions: Coblation achieves ablation, resection, and coagulation of soft tissues, in addition to hemostasis of blood vessels, obtaining satisfactory aesthetic and functional results for the patient.


REFERENCES

  1. Madrigal Díez C, Mazas Raba MR, Fernández Jiménez MI,Diego García EM, Ballestero Diego R. Hemangioma del labiosuperior tratado con éxito con propranolol. Rev PediatrAten Primaria 2011; 13 (50): 233-240.

  2. Punia H, Saavi , Kadtane S, Bumb S, Singh V. Hemangiomaof the lower lip. Heal Talk 2013; 06 (1): 32.

  3. Neville BW. Patologia oral e maxilofacial. Rio de Janeiro:Elsevier; 2011.

  4. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, BoraleviF, Thambo JB, Taïeb A. Propranolol for severe hemangiomasof infancy. N Engl J Med 2008; 358 (24): 2649-51. doi:10.1056/NEJMc0708819.

  5. Zegpi MS, Sandoval M. Indicaciones quirúrgicas en hemangiomasde la infancia. A propósito de un caso. Rev ChilenaDermatol 2008; 24 (3): 222-6.

  6. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am AcadDermatol 2003; 48: 477-493. doi: 10.1067/mjd.2003.200.

  7. Lister WA, Camb MD. The natural history of strawberrynevi. Lancet 1938; 1429-1434. https://doi.org/10.1016/S0140-6736(00)70042-0.

  8. Fost NC, Esterly NB. Successful treatment of juvenile hemangiomaswith prednisone. J Pediatr 1968; 72: 351-357.doi: 10.1016/s0022-3476(68)80208-2.

  9. Hasan Q, Tan ST, Gush J, Peters SG, Davis PF. Steroid therapyof a proliferating hemangioma: histochemical and molecularchanges. Pediatrics 2000; 105: 117-120. doi: 10.1542/peds.105.1.117.

  10. Hasan Q, Tan ST, Xu B, Davis PF. Effects of five commonlyused glucocorticoids on hemangioma in vitro. Clin ExpPharmacol Physiol 2003; 30: 140-144. doi: 10.1046/j.1440-1681.2003.03815.x.

  11. Zweifach BW, Shou Black M. The influence of the adrenalcortex on the behavior of terminal vascular beds. AnnNY Acad Sci 1953; 56: 626-633. doi: 10.1111/j.1749-6632.1953.tb27383.x.

  12. Williams EF, Stanislaw P, Dupree M, Mourtzikos K, MihmM, Shannon L. Hemangiomas in infants and children: Analgorithm for intervention. Arch Facial Plast Surg 2000; 2:103-111. doi: 10.1001/archfaci.2.2.103.

  13. Leal Lorenzo J. Hemangiomas. https://www.cun.es/enfermedadestratamientos/enfermedades/hemangiomas

  14. Dinehart SM, Kincannon J, Geronemus R. Hemangiomas:Evaluation and treatment. Dermatol Surg 2001; 27: 475-485. doi: 10.1046/j.1524-4725.2001.00227.x.

  15. Sutula FC, Glover AT. Eyelid necrosis following intralesionalcorticosteroid injection for capillary hemangioma. OphthalmicSurg 1987; 18: 103-105.

  16. Elsas FJ, Lewis AR. Topical treatment of perioocular capillaryhemangioma. J Pediatr Ophthalmol Strabismus 1993; 30:4-7. doi: 10.3928/0191-3913-19940501-06.

  17. Weber G. The treatment of cavernous haemangioma withtopical betamethasone 17 valerate. Br J Dermatol 1973;89: 649-651. doi: 10.1111/j.1365-2133.1973.tb07596.x.

  18. Sarihan H, Mocan H, Yildiz K, Abes M, Akyazici R. A newtreatment with bleomycin for complicated cutaneoushemangioma in children. Eur J Pediatr Surg 1997; 7: 158-162. doi: 10.1055/s-2008-1071080.

  19. Kullendorf CM. Efficacy of bleomycin treatment for symptomatichemangiomas in children. Pediatr Surg Int 1997;12: 526-528. doi: 10.1007/BF01258718.

  20. Gao Q, Wang C, Wen Y, Li L, Zhang J, He Z, Yang Z. [An experimentalstudy on effects of pingyangmycin on vessels].Hua Xi Kou Qiang Yi Xue Za Zhi 2001; 19 (3): 184-7. Chinese.

  21. Wu L, Sun G. Treatment of hemangioma with an angiogenesisinhibitor pingyangmycin. Ind Pediatr 2000; 37: 636-639.

  22. Li F, Cassady JR, Barnett E. Cancer mortality following irradiationin infancy for hemangiomas. Radiol 1974; 113:177-178. doi: 10.1148/113.1.177.

  23. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL.Treatment of pulmonary hemangiomatosis with recombinantinterferon alfa-2a. N Engl J Med 1989; 320: 1197-1200.doi: 10.1056/NEJM198905043201807.

  24. Greinwald JH, Burke DK, Bonthius DJ, Bauman NM, SmithRJH. An update on the treatment of hemangiomas in childrenwith interferon alfa-2a. Arch Otolaryngol Head NechSurg 1999; 125: 21-27. doi:10.1001/archotol.125.1.21.

  25. Dubois J, Hershon L, Carmant L, Belanger S, Leclerc JM,David M. Toxicity profile of interferon alfa 2 b in children:a prospective evaluation. J Pediatr 1999; 135: 782-785. doi:10.1016/s0022-3476(99)70104-6.

  26. Jasper J, Stifelman Camilotti R, Miranda R, Dourado V, etal. Treatment of lip hemangioma using forced dehydrationwith induced photocoagulation via diode laser: report ofthree cases. Oral Surg Oral Med Oral Pathol Oral Radiol2015; 119 (3): e89-94. doi: 10.1016/j.oooo.2014.03.005.

  27. Myers T D, McDaniel JD. The pulsed Nd:YAG dental laser:review of clinical applications. J Calif Dent Assoc 1991; 19(11): 25-30.

  28. White JM, Chaudhry S, Kudler J, Sekandari N, Schoelch M,Silverman S. Nd:YAG and CO2 laser therapy of oral mucosallesions. J Clin Laser Med Surg 1998; 16 (6): 299-304. doi:10.1089/clm.1998.16.299.

  29. Dua Cebeci, Seide Karacel, Sirin Yasar. Venous lakes ofthe lips successfully treated with a sclerosing agent 1%polidocanol: analysis of 25 report cases. Int J Surg CaseRep 2021; 78: 265-269. doi: 10.1016/j.ijscr.2020.12.057.

  30. Miller SH, Smith RL, Schochat SJ. Compression treatmentof hemangiomas. Plast Reconstr Surg 1976; 58: 573-579.doi: 10.1097/00006534-197611000-00007.

  31. Kaplan M, Paller AS. Clinical pearl: use of self-adhesive,compressive wraps in the treatment of limb hemangiomas.J Am Acad Dermatol 1995; 32: 117-118. doi: 10.1016/0190-9622(95)90196-5.

  32. Mariano F, Vargas P, Coletta R, Lopes M. Sclerotherapy followedby surgery for the treatment of oral hemangioma: areport of two cases. Gen Dent 2011; 59 (3): e121-5.

  33. Hemal AK, Aron M, Wadhwa SN. Intralesional sclerotherapyin the management of hemangiomas of the glanspenis. J Urol 1998; 159: 415-417. doi: 10.1016/s0022-5347(01)63936-3.

  34. Reischle S, Schuller-Petrovic S. Treatment of capillaryhemangiomas of early childhood with a new method ofcryosurgery. J Am Acad Dermatol 2000; 42: 809-813. doi:10.1067/mjd.2000.103985.

  35. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Mac DonaldD, Folkman J, et al. Spastic diplegia as a complicationof interferon alfa 2 a treatment of hemangiomas of infancy.J Pediatr 1998; 132: 527-530. doi: 10.1016/s0022-3476(98)70034-4.

  36. Esterly NB. Hemangiomas. En: Harper J, Oranje A, ProseN, editors. Textbook of pediatric dermatology. Oxford:Blackwell Science, 2000: 997-1016.

  37. https://www.smith-nephew.com/professional/products/all-products/coblator-ii-ent/

  38. Quintero Z, Gonzalez N, Gonzalez SL, Sanchez L. Uso delpropranolol en hemangioma segmentario de la cara. Apropósito de un caso. Medisur 2020; 18 (5).

  39. Ashwag A, Afrah A, Shahad A, Ahad A, Hadeel A, Hend S.Hemangioma in the lower labial vestibule of an elevenyear-old girl: A case report. World J Clin Cases 2022; 10 (5):1617-1622. doi: 10.12998/wjcc. v10.i5.1617.

  40. Zaldívar-Reyna O, Parra-Soto I, Guerrero-Ruiz LI, Gil-Hernández G, et al. Tratamiento con propanolol enhemangioma facial de alto flujo. Rev Hosp Jua Mex2014; 81 (2).




2020     |     www.medigraphic.com